Press Room

Share

House Set to Pass Relief Bill Expanding Access to Health Coverage

Senate Should Quickly Pass Bill with Increased Health Coverage Subsidies, Medicaid Incentives and Biomedical Research Funds

February 26, 2021

Washington, D.C.—The U.S. House of Representatives is set to pass legislation today that would increase access to health coverage for millions of Americans, including cancer patients and survivors, as part of its pandemic relief package.

The bill increases the generosity of subsidies to cover the costs of marketplace health plans—including offering subsides to those who are receiving unemployment benefits—offers financial support to cover the bulk of premium costs for laid off workers who choose to keep their employer-sponsored health care plans and boosts the federal reimbursement for states to expand their Medicaid programs.

A statement from Lisa Lacasse, president of the American Cancer Society Cancer Action Network (ACS CAN):

“The passage of this bill in the House would bring millions of Americans who have lost their health coverage due to the pandemic—whether through job loss, reduced hours or other means—closer to gaining meaningful coverage. Access to comprehensive health coverage is always essential, but its importance has become even more apparent during this ongoing public health emergency and we welcome the added assistance to help patients get the care they need.

“We also urge the Senate to add aid to biomedical researchers struggling to restart their work amidst the ongoing pandemic to the legislation. Clinical trials provide a lifeline for patients of all kinds, including those with cancer, and the interruptions, delays and costs to restarting these trials are significant. Allocating $10 billion to the National Institutes of Health for this specific purpose would ensure years of valuable research and potential for new and life-saving treatments are not lost to the pandemic.

“By providing more ways for people to afford comprehensive health care and ensuring critical biomedical research can resume, Congress can significantly improve our nation’s health outcomes for years to come. The House has taken the first step toward this future and we urge the Senate to quickly do the same.”

More Press Releases AboutCancer Research Funding, Access to Health Insurance, COVID-19, Access to Health Care, National

Media Contacts

Allison Miller
Director, Media Advocacy
Washington, D.C.
[email protected]
202-585-3241

Related Press Releases

March 21, 2024

Congress Considers FY24 Appropriations Bill That Prioritizes Cancer Research and Proven Cancer Screening Funding Amidst Difficult Budget Cycle

WASHINGTON, D.C.— March 21, 2024 — Today, Congress released a series of spending bills aimed to finalize FY2024 funding that includes a $300 million increase in funding for the National Health Institute (NIH) base budget, including a $120 million increase in discretionary funding for the National Cancer Institute (NCI), a modest $500,000 increase for the Centers for Disease Control and Prevention (CDC) cancer screening and prevention programs and maintains the current funding level for the Advanced Research Projects Agency for Health (ARPA-H) at $1.5 billion. At NIH, the bill also includes a first-time appropriation of $12.5 million in dedicated funding for the development of palliative care research at NIH and a new $6 million initiative for Improving Native American Cancer Outcomes. Within the Department of Defense (DoD), the bill includes a $110 million for the Prostate Cancer Research Program. 

Read More
March 24, 2023

New Jersey is taking a giant leap forward in the war against cancer. Here's how

The following originally appeared in the Asbury Park Press on March 24, 2023.

 

Read more
March 11, 2024

President’s FY25 Budget Prioritizes Funding for Cancer Research and Prevention

The American Cancer Society Cancer Action Network (ACS CAN) is pleased to see President Biden’s continued focus on and dedication to achieving the goal of the Cancer Moonshot to end cancer as we know it, for everyone.

Read more